All Updates

All Updates

icon
Filter
Earnings/results
Zoom smashes analyst estimates in impressive Q4 earnings release
Remote Work Tools
Mar 1, 2021
This week:
Partnerships
Twelve Labs partners with AWS to make videos searchable
Foundation Models
Yesterday
Partnerships
Apple discloses use of AWS GenAI chips at re:Invent 2024 conference
Generative AI Infrastructure
Yesterday
Product updates
AWS launches Automated Reasoning checks to combat AI hallucinations
Generative AI Infrastructure
Yesterday
Partnerships
Allianz Partners and Uber partner to launch vehicle interruption cover for UK drivers
InsurTech: Commercial Lines
Dec 3, 2024
Funding
Jove Insurance raises USD 4.4 million in seed funding for product enhancement
InsurTech: Commercial Lines
Dec 3, 2024
Funding
Orakl Oncology raises EUR 11 million in seed funding to commercialize products
AI Drug Discovery
Dec 3, 2024
FDA approval
Lantern Pharma receives second FDA Fast Track Designation for LP-184 oncology candidate
AI Drug Discovery
Dec 3, 2024
Partnerships
AI Proteins partners with BMS to develop novel mini-protein-based therapeutics
AI Drug Discovery
Dec 3, 2024
Product updates
Partnerships
SoftServe introduces GenAI drug discovery solution with NVIDIA
AI Drug Discovery
Dec 3, 2024
Funding
Maze Therapeutics raises USD 115 million in Series D funding to develop pipeline programs
Precision Medicine
Dec 3, 2024
Remote Work Tools

Remote Work Tools

Mar 1, 2021

Zoom smashes analyst estimates in impressive Q4 earnings release

Earnings/results

  • Zoom reported an adjusted EPS of USD 1.22 (up 8x from USD 0.15 a year ago) for Q4 FY2021, significantly exceeding analyst consensus expectations of USD 0.79. Zoom’s revenue growth was impressive as it increased by 369% YoY to USD 882 million, also beating analyst estimates of USD 812 million. This is especially significant given that it follows 367% revenue growth in the previous quarter.

  • Zoom provided revenue guidance for the fiscal year 2022 in the range of USD 3.76 and USD 3.78 billion, implying around 42% YoY growth. Adjusted EPS guidance was also raised between USD 3.59 and USD 3.65, implying EPS growth in the range of 8% and 9% in FY2022.

  • The Q4 revenue growth was supported by a 470% YoY (about 8% QoQ) increase in “customers with more than 10 employees” to 467,100. Active customers (trailing 12 month revenue greater than USD 100,000) increased to around 1,650, reflecting a 156% increase YoY (about 28% QoQ). 

  • Zoom’s adjusted gross margin reduced by about 13 percentage points (pps) to 71.3% in Q4 FY2021 compared to the previous year. However, this was due to a higher number of free users and increased utilization of public cloud services due to the Covid-19 pandemic. Adjusted gross margins increased by 3 pps compared to the previous quarter. Adjusted operating expenses reduced to 30% of revenue in Q4, which led to  EBIT of USD 361 million (41% EBIT margin) compared to EBIT of USD 38 million (20% EBIT margin) in the previous year. 

  • Zoom’s stock price rose around 11% in after-hours trading.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.